Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Surgalign Holdings, Inc. (SRGA : NSDQ)
 
 • Company Description   
Surgalign Holdings Inc. is a surgical implant company. Surgalign Holdings Inc., formerly known as RTI Surgical Holdings Inc., is headquartered in Deerfield, Illinois.

Number of Employees: 231

 
 • Price / Volume Information   
Yesterday's Closing Price: $5.19 Daily Weekly Monthly
20 Day Moving Average: 96,925 shares
Shares Outstanding: 6.62 (millions)
Market Capitalization: $34.34 (millions)
Beta: 2.22
52 Week High: $59.40
52 Week Low: $4.28
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -26.46% -16.41%
12 Week -43.92% -39.61%
Year To Date -75.88% -70.70%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
520 LAKE COOK ROAD SUITE 315
-
DEERFIELD,IL 60015
USA
ph: 224-303-4651
fax: 386-418-0342
info@surgalign.com http://www.surgalign.com
 
 • General Corporate Information   
Officers
Terry M. Rich - Chief Executive Officer;President
Sheryl L. Conley - Chair of the Board of Directors
Christopher Thunander - Chief Accounting Officer;Vice President
Thomas A. McEachin - Director
Mark D. Stolper - Director

Peer Information
Surgalign Holdings, Inc. (CHCR)
Surgalign Holdings, Inc. (ESRX)
Surgalign Holdings, Inc. (MYDP)
Surgalign Holdings, Inc. (GBCS)
Surgalign Holdings, Inc. (LAXAF)
Surgalign Holdings, Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 86882C204
SIC: 3842
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/05/22
Share - Related Items
Shares Outstanding: 6.62
Most Recent Split Date: 5.00 (0.03:1)
Beta: 2.22
Market Capitalization: $34.34 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/05/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.34
Price/Cash Flow: -
Price / Sales: 0.39
EPS Growth
vs. Year Ago Period: 33.33%
vs. Previous Quarter: 27.27%
Sales Growth
vs. Year Ago Period: -11.53%
vs. Previous Quarter: -5.61%
ROE
03/31/22 - -169.33
12/31/21 - -137.32
09/30/21 - -128.61
ROA
03/31/22 - -39.63
12/31/21 - -35.69
09/30/21 - -36.94
Current Ratio
03/31/22 - 3.57
12/31/21 - 1.96
09/30/21 - 2.46
Quick Ratio
03/31/22 - 2.76
12/31/21 - 1.47
09/30/21 - 1.97
Operating Margin
03/31/22 - -64.52
12/31/21 - -58.62
09/30/21 - -57.78
Net Margin
03/31/22 - -79.07
12/31/21 - -93.54
09/30/21 - -146.88
Pre-Tax Margin
03/31/22 - -123.71
12/31/21 - -136.79
09/30/21 - -161.51
Book Value
03/31/22 - 3.88
12/31/21 - 1.69
09/30/21 - 10.15
Inventory Turnover
03/31/22 - 1.16
12/31/21 - 1.16
09/30/21 - 1.35
Debt-to-Equity
03/31/22 - 0.39
12/31/21 - 1.21
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 43.83
12/31/21 - 70.82
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©